News
Advancements in Nitrosamine Detection and Control
Nitrosamines are unintended but potentially harmful impurities that can emerge during the manufacturing of pharmaceuticals. Recognized for their carcinogenic potential, the detection and control of these impurities are critical for ensuring drug safety. Recent advancements in analytical technologies have...
News
Affordable Medicines Call For The Supply Chain Resilience
The Central Drugs Standard Control Organization (CDSCO), which happens to be India’s central regulatory body for pharmaceuticals, on April 30, 2024, went on to withdraw the power held by the state governments to issue NOCs for manufacturing banned, unapproved,...
IT & Data Management
8 Key Elements – Quality Management Integration In Labs
Given the intricacy of lab operations, manual management in terms of laboratory quality can indeed be very challenging. A cloud-based lab quality management system can help automate workflows, offer visibility as well as traceability, help with risk management, change...
Drug Research
Laboratory-Developed Tests Set To Be Regulated By The FDA
The FDA’s final rule that solidifies its presence and authority on Laboratory-Developed Tests- LDTs goes on to mark a prominent shift in the regulation as far as the diagnostics sector is concerned.
The rule very well makes it pretty clear...
News
Charles River Labs Attain 100% Renewable Electricity Feat
Pharmaceutical and microbial testing company- Charles River Laboratories happens to be now operating all of its international branches with completely 100% renewable electricity as of Q1 of 2024.
It is worth noting that the UK-based company went on to reach...
News
All Infinity Laboratories Facilities Are Now ISO Certified
Infinity Laboratories has gone on to achieve successful accreditation across all its sites pertaining to their ISO/IEC standards, thereby highlighting its commitment to making sure that high standards of excellence and quality within the field of chemical and microbiology...
News
Effect of The EU Sustainability Directive On Supply Chains
It is worth noting that 84% of pharma and healthcare companies go on to consider that the new EU Corporate Sustainability Due Diligence Directive- CDDDD happens to be nothing short of an opportunity so as to sync human rights...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read
